Bots, editor, reviewer, Administrators
13,941
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 4,657: | Line 4,657: | ||
"title" : "Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia", | "title" : "Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia", | ||
"pmid" : "12637609" | "pmid" : "12637609" | ||
}, | |||
{ | |||
"timestamp" : "2024-05-20T13:33:05Z", | |||
"briefDesignDescription" : "IV iron in critical illness", | |||
"fulltexturl" : "https://link.springer.com/article/10.1007%2Fs00134-016-4465-6", | |||
"pageid" : 3651, | |||
"pdfurl" : "https://link.springer.com/content/pdf/10.1007/s00134-016-4465-6.pdf", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Litton E, <i>et al</i>. \"Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial\". <i>Intensive Care Med</i>. 2016. 42:1715-1722.", | |||
"subspecialties" : "Critical Care;Hematology", | |||
"expansion" : "", | |||
"statusUsableDate" : "2024-04-30", | |||
"briefResultsDescription" : "IV iron did not reduce transfusion requirements", | |||
"published" : "2016-11-01", | |||
"pageName" : "IRONMAN", | |||
"diseases" : "Anemia;Critical Illness", | |||
"abbreviation" : "IRONMAN", | |||
"title" : "Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial", | |||
"pmid" : "27686346" | |||
}, | }, | ||
{ | { | ||